Back to Products

5-Amino-1MQ

LIMITED EVIDENCE
PEPTIDESfat lossmetabolism

A peptide that inhibits NNMT enzyme to increase cellular metabolism.

How It Works

Inhibits nicotinamide N-methyltransferase (NNMT), which may increase NAD+ levels and cellular energy metabolism.

Benefits

  • ✓Improved body composition
  • ✓Enhanced fat metabolism
  • ✓Increased energy expenditure
  • ✓Potential longevity benefits

Potential Side Effects

  • ⚠Limited human safety data
  • ⚠Possible metabolic changes
  • ⚠Long-term effects unknown

FDA Status

Not FDA-approved - research compound

Clinical Evidence

Strong animal data showing metabolic improvements. Early human use suggests noticeable effects but lacks large-scale trials.

Common Dosage

50mg daily

⚠ Always consult with a healthcare professional before starting any new supplement or treatment.

Related Products

Mounjaro (Tirzepatide)

A GLP-1/GIP dual agonist medication for weight loss and blood sugar control.

Related News & Research

GLP-1 Agonists Continue to Transform Weight Loss Treatment in 2025

Jan 10, 2025

New data shows dual GLP-1/GIP agonists like Tirzepatide achieving unprecedented weight loss results with improved patient compliance.

Medical Disclaimer

The information provided on this page is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any new treatment, supplement, or making changes to your health regimen.